Product Overview
Double-stranded RNA (dsRNA) is a common byproduct of T7-based in vitro transcription and can contribute to unwanted innate immune activation. Hyasen T7 RNA Polymerase (low dsRNA) is an engineered variant designed to reduce dsRNA byproduct formation compared with wild-type T7 RNA Polymerase. Operating under standard IVT conditions at 37°C, the enzyme enables RNA synthesis from T7 promoter-containing DNA templates while helping address dsRNA-related challenges in mRNA research and development.
Components
| Components | 5KU | 50KU | 500KU | 5000KU |
| T7 RNA Polymerase (low dsRNA) 50 U/μL | 0.1 mL | 1 mL | 10 mL | 100 mL |
| 10× T7 Buffer | 2 ×0.1 mL | 2 ×1 mL | 2 × 10 mL | 2 × 100 mL |
Product Features
- Reduced dsRNA Byproducts: Engineered to produce less dsRNA than wild-type T7 RNA Polymerase.
- Designed for mRNA IVT: Supports RNA synthesis workflows where dsRNA reduction is important.
- Standard Reaction Temperature: Performs IVT at 37°C without requiring elevated-temperature conditions.
FAQ
Q1: What is low-dsRNA T7 RNA Polymerase?
It is an engineered T7 RNA Polymerase variant that produces fewer dsRNA byproducts during in vitro transcription compared with wild-type T7 RNA Polymerase.
Q2: Why is reducing dsRNA important in mRNA synthesis?
dsRNA byproducts can activate innate immune responses and affect downstream mRNA applications. Reducing dsRNA formation during IVT can help address this challenge.
Q3: Does low-dsRNA T7 RNA Polymerase eliminate the need for RNA purification?
No. Although the enzyme reduces dsRNA byproduct formation, downstream purification may still be required to remove residual dsRNA and other reaction impurities.